Transdermal Trigeminal Electrical Neuromodulation on Mild Cognitive Impairment With Insomnia

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
InsomniaAlzheimer DiseaseMild Cognitive ImpairmentAmyloid
Interventions
DEVICE

Transdermal trigeminal electrical neuromodulation(Cefaly)

The Cefaly device delivers electrical micro-impulses through a self-adhesive electrode which is placed over the participant's forehead, where the supratrochlear and supraorbital branches of the ophthalmic division of the trigeminal nerve are located. Rectangular, biphasic impulses with an electrical mean equal to zero are transmitted. The impulse width is 250μs, frequency is 60Hz, and the maximum intensity of 16mA is over 14 minutes

Trial Locations (1)

Unknown

RECRUITING

St.Vincent's Hospital, the Catholic University of Korea, Suwon

All Listed Sponsors
lead

Saint Vincent's Hospital, Korea

OTHER